Noninvasive lung fluid monitor for heart failure treatment
Part of Heart & circulation clinical trials.
This study tests a wearable device that measures fluid in the lungs to help guide treatment for acute heart failure. It may help doctors better manage your condition and reduce symptoms like shortness of breath.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 21 to 85 years old
- You are currently hospitalized for acute heart failure with symptoms like shortness of breath, fluid in the lungs on X-ray or CT, and high BNP levels
- You need IV diuretics (water pills) for your condition
- You do not have severe kidney disease (eGFR at least 20) or need dialysis
- You have not had a heart transplant or a device like a left ventricular assist device
- You are not pregnant and can follow the study procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device that measures fluid in your lungs without needles or surgery. It may help your doctor manage heart failure better, especially if you've been in the hospital recently or have symptoms like shortness of breath.
This study uses a noninvasive device (ReDS) to estimate fluid buildup in people hospitalized with acute heart failure. It may help doctors monitor fluid status and guide care more accurately during a hospital stay.
This study tests whether a wearable device that monitors your heart and transmits data to your doctor can help optimize your heart failure medications after hospitalization. The goal is to prevent future hospital visits and improve your health by keeping closer tabs on how your body responds to treatment adjustments.
This trial tests a small, portable device worn on the chest that measures changes in fluid levels in your lungs to help detect early signs of fluid buildup (pulmonary congestion). This could help people with heart failure avoid emergency hospital visits.
This study tests whether a CardioPulmonary Management (CPM) system device used at home is safe and can improve outcomes for people with chronic heart failure. It may help manage symptoms and reduce complications, especially for higher-risk patients.
This study looks at how a small monitor inside the blood vessel to the lungs helps manage heart failure. It aims to improve care for people with advanced heart failure.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.